Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients

2019 New England Journal of Medicine 4,463 citations

Abstract

Among patients with severe aortic stenosis who were at low surgical risk, the rate of the composite of death, stroke, or rehospitalization at 1 year was significantly lower with TAVR than with surgery. (Funded by Edwards Lifesciences; PARTNER 3 ClinicalTrials.gov number, NCT02675114.).

Keywords

MedicineValve replacementStenosisAortic valve replacementCardiologyInternal medicineAortic valve stenosisBalloonSurgeryAortic valve

Affiliated Institutions

Related Publications

Publication Info

Year
2019
Type
article
Volume
380
Issue
18
Pages
1695-1705
Citations
4463
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

4463
OpenAlex

Cite This

Michael J. Mack, Martin B. Leon, Vinod H. Thourani et al. (2019). Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients. New England Journal of Medicine , 380 (18) , 1695-1705. https://doi.org/10.1056/nejmoa1814052

Identifiers

DOI
10.1056/nejmoa1814052